Clinical Trial Update: Phase I Nicotinic Agonist Treatment Trial for Autism [Phase 1]

View source ↗

Summary

Phase I nicotinic agonist trial for autism was terminated. No results are provided in the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Snippet

Sponsor: University of Colorado, Denver | Conditions: Autism | Phase 1 | Status: TERMINATED